

Drug Class: Beta-2 Agonist / Alpha-2 Antagonist / Fat Burner
Active Substance: Clenbuterol 30 mcg, Yohimbine 5.6 mg
Strength: 5.8 mg/mL
Amount: 10 mL Vial
Active Life: 24–36 hours
Average Dose: 0.5–1 mL per day
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: 0%
Androgenic Rate: 0%
Manufacturer: Dragon Pharma
Laboratory Test: View Result
Dragon Pharma Helios is a powerful injectable fat-burning solution that combines two synergistic agents—Clenbuterol and Yohimbine—into a single compound. Designed for physique athletes and serious dieters, Helios targets stubborn fat areas, increases thermogenesis, and preserves lean muscle mass during caloric restriction.
Each mL of Helios contains 30 mcg of Clenbuterol and 5.6 mg of Yohimbine, making it one of the most effective injectable fat loss products available. Clenbuterol, a potent beta-2 adrenergic agonist, boosts metabolic rate and lipolysis. Yohimbine, an alpha-2 antagonist, enhances blood flow and mobilizes stubborn fat from resistant areas such as the hips, lower back, and abdomen.
As noted by the National Institutes of Health, Yohimbine's efficacy is closely tied to fat loss in athletes, particularly when paired with beta-agonists like Clenbuterol under fasted conditions.
Helios stimulates the central nervous system, increasing energy expenditure and breaking down stored fat for fuel. Clenbuterol promotes thermogenesis, while Yohimbine blocks alpha-2 receptors that normally inhibit fat burning. This combination works exceptionally well when injected subcutaneously into stubborn fat areas, making it popular during pre-contest prep or cutting cycles.
While systemic fat loss will occur from daily Helios use, many athletes inject it locally—often into abdominal, lower back, or thigh fat—to improve circulation and directly impact resistant adipose tissue. This targeted method, combined with cardio and a deficit diet, accelerates visible results.
Begin with 0.5 mL daily, split into two injections, and gradually increase to 1 mL/day depending on tolerance. Injections are best administered subcutaneously, ideally in the morning or pre-cardio. Maximum duration is typically 2–3 weeks on, followed by a 1–2 week break to avoid beta-2 receptor desensitization.
Helios is often used alongside:
Helios may cause increased heart rate, restlessness, sweating, insomnia, or jitteriness—especially at higher doses. Individuals sensitive to stimulants should begin at the lowest dose. Yohimbine may also elevate anxiety or blood pressure in some users. Do not combine Helios with other stimulants such as ephedrine or high-dose caffeine.
Lab results from September 2023 confirm Dragon Pharma's Helios matches label claim: 65.50 mcg Clenbuterol and 6.53 mg Yohimbine per mL. This ensures purity and accurate dosing for optimal fat loss outcomes.
Helios is recommended for intermediate and advanced athletes seeking to:
Looking for a pharmaceutical-grade injectable fat loss compound? You can order this premium Clenbuterol and Yohimbine blend from a verified Dragon Pharma supplier with USA shipping options. Each vial is GMP-manufactured, batch-verified, and sealed for potency and safety.
Helios is typically injected subcutaneously, either systemically or directly into stubborn fat areas such as the abdomen or thighs. Use a fine insulin syringe for comfort and absorption.
Yes. While overall fat loss is systemic, subcutaneous injection of Helios may help increase lipolysis in resistant fat areas when combined with fasted cardio and a proper diet.
Helios can be used by women at lower doses (0.25–0.5 mL/day), but it's important to monitor for stimulant-related side effects. Always start low and assess tolerance.
Yes. Helios should be used for 2–3 weeks followed by a 1–2 week break to avoid receptor desensitization. Cycling improves long-term fat loss efficacy and safety.
Please log in to write Helios 5.8 mg review.
Drug Class: Beta-2 Adrenergic Agonist
Active Substance: Clenbuterol Hydrochloride
Strength: 40 mcg/tablet
Amount: 100 tablets
Active Life: 36–48 hours
Average Dose: 20–120 mcg/day
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: Not anabolic
Androgenic Rate: None
Manufacturer: Stealth Labs
Laboratory Test: View Result
Shipped Without Label!
Drug Class: Beta-2 Adrenergic Agonist
Active Substance: Clenbuterol Hydrochloride
Strength: 40 mcg/tablet
Amount: 100 tablets
Active Life: 36–48 hours
Average Dose: 40–120 mcg/day
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: Not Applicable
Androgenic Rate: Not Applicable
Manufacturer: Dragon Pharma
Laboratory Test: View Result
Drug Class: Beta-2 Adrenergic Agonist
Active Substance: Clenbuterol Hydrochloride
Strength: 40 mcg/tablet
Amount: 100 tablets
Active Life: 36–48 hours
Average Dose: 40–120 mcg/day
Liver Toxicity: None
Aromatization Rate: None
Anabolic Rate: Not Applicable
Androgenic Rate: Not Applicable
Manufacturer: Axiolabs
Laboratory Test: View Result
Drug Class: Beta-2 Agonist, Bronchodilator
Active Substance: Clenbuterol Hydrochloride
Strength: 40 mcg/tablet
Amount: 100 Tablets
Active Life: 48–72 Hours
Average Dose: 40–160 mcg/day (based on tolerance)
Liver Toxicity: No
Aromatization: No
Manufacturer: Kalpa Pharmaceuticals
Laboratory Test: View Result
Drug Class: Beta-2 Adrenergic Agonist
Active Substance: Clenbuterol Hydrochloride
Strength: 40 mcg/tablet
Amount: 100 tablets
Active Life: ~36 hours
Average Dose: 40–120 mcg/day
Liver Toxicity: Low
Aromatization Rate: None
Anabolic Rate: Mild (in animals)
Androgenic Rate: None
Manufacturer: British Dragon
Laboratory Test: View Result